BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22945782)

  • 1. Nephroprotective role of salacia chinensis in diabetic CKD patients: a pilot study.
    Singh RG; Rathore SS; Kumar R; ; Agarwal A; Dubey GP
    Indian J Med Sci; 2010 Aug; 64(8):378-84. PubMed ID: 22945782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: a prospective study.
    Singh RG; Rathore SS; Wani IA; ; Agrawal A; Dubey GP
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):61-6. PubMed ID: 25579717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of mangiferin isolated from Salacia chinensis on biochemical and hematological parameters in rats with streptozotocin-induced diabetes.
    Sellamuthu PS; Arulselvan P; Fakurazi S; Kandasamy M
    Pak J Pharm Sci; 2014 Jan; 27(1):161-7. PubMed ID: 24374436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperlipidemic activity of Salacia chinensis root extracts in triton-induced and atherogenic diet-induced hyperlipidemic rats.
    Sikarwar MS; Patil MB
    Indian J Pharmacol; 2012 Jan; 44(1):88-92. PubMed ID: 22345877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of NR-Salacia on post-prandial hyperglycemia: A randomized double blind, placebo-controlled, crossover study in healthy volunteers.
    Koteshwar P; Raveendra KR; Allan JJ; Goudar KS; Venkateshwarlu K; Agarwal A
    Pharmacogn Mag; 2013 Oct; 9(36):344-9. PubMed ID: 24124287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease.
    Koay YY; Tan GCJ; Phang SCW; Ho JI; Chuar PF; Ho LS; Ahmad B; Abdul Kadir K
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
    Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deceleration of Disease Progress Through Ayurvedic Treatment in Nondialysis Stages IV-V Patients with Chronic Renal Failure: A Quasi-Experimental Clinical Pilot Study with One Group Pre- and Postdesign and Two Premeasurements.
    Patel M; Patel M; Patel K; Wischnewsky M; Stapelfeldt E; Kessler CS; Gupta SN
    J Altern Complement Med; 2020 May; 26(5):384-391. PubMed ID: 32223566
    [No Abstract]   [Full Text] [Related]  

  • 10. Appetite and Gut Hormones Response to a Putative α-Glucosidase Inhibitor, Salacia Chinensis, in Overweight/Obese Adults: A Double Blind Randomized Controlled Trial.
    Hao L; Schlussel Y; Fieselmann K; Schneider SH; Shapses SA
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28805670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Dependent Suppression of Postprandial Hyperglycemia and Improvement of Blood Glucose Parameters by
    Kobayashi M; Akaki J; Ninomiya K; Yoshikawa M; Muraoka O; Morikawa T; Odawara M
    J Med Food; 2021 Jan; 24(1):10-17. PubMed ID: 33370165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial.
    Shah AP; Shen JI; Wang Y; Tong L; Pak Y; Andalibi A; LaPage JA; Adler SG
    PLoS One; 2016; 11(3):e0152357. PubMed ID: 27019421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
    Heerspink HJL; Parving HH; Andress DL; Bakris G; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray JJV; Melnick JZ; Miller MG; Pergola PE; Perkovic V; Tobe S; Yi T; Wigderson M; de Zeeuw D;
    Lancet; 2019 May; 393(10184):1937-1947. PubMed ID: 30995972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of serum homocysteine levels in diabetic patients on haemodialysis.
    Oishi K; Nagake Y; Yamasaki H; Fukuda S; Ichikawa H; Ota K; Makino H
    Nephrol Dial Transplant; 2000 Jun; 15(6):851-5. PubMed ID: 10831640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo controlled trial of vitamin B
    Kwok T; Lee J; Ma RC; Wong SY; Kung K; Lam A; Ho CS; Lee V; Harrison J; Lam L
    Clin Nutr; 2017 Dec; 36(6):1509-1515. PubMed ID: 27823800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ITS 2 and RNA secondary structure-based analysis reveals a clear picture on phylogeny of South Indian Salacia spp.
    Anaz K M; N S; A R; M V D
    Comput Biol Chem; 2021 Apr; 91():107438. PubMed ID: 33524844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
    Freedman BI; Wuerth JP; Cartwright K; Bain RP; Dippe S; Hershon K; Mooradian AD; Spinowitz BS
    Control Clin Trials; 1999 Oct; 20(5):493-510. PubMed ID: 10503809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salacia chinensis exerts its antidiabetic effect by modulating glucose-regulated proteins and transcription factors in high-fat diet fed-streptozotocin-induced type 2 diabetic rats.
    Erten F; Orhan C; Tuzcu M; Er B; Defo Deeh PB; Sahin N; Özercan IH; Juturu V; Sahin K
    J Food Biochem; 2020 Dec; 44(12):e13513. PubMed ID: 33020991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids and the progression of nephropathy in type 1 diabetes.
    Thomas MC; Rosengård-Bärlund M; Mills V; Rönnback M; Thomas S; Forsblom C; Cooper ME; Taskinen MR; Viberti G; Groop PH
    Diabetes Care; 2006 Feb; 29(2):317-22. PubMed ID: 16443880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
    Baigent C; Landray M; Leaper C; Altmann P; Armitage J; Baxter A; Cairns HS; Collins R; Foley RN; Frighi V; Kourellias K; Ratcliffe PJ; Rogerson M; Scoble JE; Tomson CR; Warwick G; Wheeler DC
    Am J Kidney Dis; 2005 Mar; 45(3):473-84. PubMed ID: 15754269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.